326 completed, 113 recruiting, 64 terminated, 52 unknown. 237 Phase 2, 128 Phase 1, 105 Not applicable, 47 Phase 3, 14 Early Phase 1.
Follow Neoplasms, Vascular Tissue: new trials by email Literature Review of Neoplasms, Vascular Tissue trials Research Report on Neoplasms, Vascular Tissue
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ceritinib Treatment for Recurrent Meningiomas Ceritinib - Recurrent Meningioma, Grade I and Grade II | Phase 2 | Not yet recruiting | Kevin Petrecca | 10 | 2027-01-01 | 2026-10-23 |
| A Study of ONC201 for Refractory Meningioma ONC201 - Meningioma, Refractory Meningioma | Phase 2 | Withdrawn | University of Nebraska | 2026-12-01 | 2026-01-26 | |
| Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO Trial Biospecimen Collection, Computed Tomography, Magnetic Resonance Imaging - Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8 | Phase 2 | Not yet recruiting | Fred Hutchinson Cancer Center | 50 | 2026-12-01 | 2026-09-17 |
| China Treatment Trial for Tumor in Sellar Region With Unruptured Intracranial Aneurysm Tumor resection followed by aneurysm treatment, Aneurysm treatment followed by tumor resection, Observation - Unruptured Intracranial Aneurysms, Pituitary Neuroendocrine Tumor | Active not recruiting | Cheng sen | 608 | 2026-10-20 | 2026-10-21 | |
| Using an Artificial Intelligence (AI) Tool for Melanoma Diagnosis Clinical decision support tool - Malignant Melanoma of Skin, Other and Unspecified Malignant Neoplasm of Skin | Phase 3 | Recruiting | Memorial Sloan Kettering Cancer Center | 14000 | 2026-10-15 | 2026-10-22 |
| Preoperative Embolization for Highly Vascular Brain Tumors Preoperative Endovascular Embolization - Brain Neoplasms, Meningioma | Not applicable | Not yet recruiting | Assiut University | 55 | 2026-10-01 | 2026-09-17 |
| Neurocutaneous Syndromes in Children: Prevalence and Clinical Characteristics Sturge-Weber Syndrome, Neurocutaneous Syndromes | Not yet recruiting | Assiut University | 100 | 2026-09-20 | 2026-09-28 | |
| Pharmacoscopy for Patients With Refractory Primary Brain Tumors Pharmacoscopy 1.0 - Brain (Nervous System) Cancers, Glioblastoma | Phase 2 | Recruiting | University of Zurich | 40 | 2026-09-11 | 2026-09-21 |
| Paclitaxel and Pegylated Liposomal Doxorubicin for Treatment of HIV-related Kaposi Sarcoma Pegylated liposomal doxorubicin, Paclitaxel - Kaposi Sarcoma, HIV-1-infection | Phase 3 | Not yet recruiting | AIDS Malignancy Consortium | 130 | 2026-09-01 | 2026-01-23 |
| A Study of Propranolol to Treat Kaposi Sarcoma Propranolol - Kaposi Sarcoma | Phase 2 | Recruiting | AIDS Malignancy Consortium | 25 | 2026-08-31 | 2026-10-05 |
| IN10018 in Combination With Dalpiciclib for Progressive Meningiomas Ifebemtinib, Dalpiciclib - Meningioma, CDK4/6 Inhibitor | Phase 1 | Recruiting | Capital Medical University | 24 | 2026-08-31 | 2026-10-21 |
| Direct Comparison of Ga-68-DOTATATE and Ga-68-DOTATOC Ga-68- DOTATATE, Ga-68-DOTATOC - Meningioma | Phase 2 | Withdrawn | Weill Medical College of Cornell University | 2026-08-01 | 2026-08-31 | |
| Rapamycin Dose-Ranging Efficacy Study in Port Wine Stains Rapamycin cream, Pulsed dyed laser - Port Wine Stains | Phase 2 | Not yet recruiting | AFT Pharmaceuticals, Ltd. | 30 | 2026-08-01 | 2026-07-01 |
| A Phase 2 Study of Sirolimus for Injection (Albumin-bound) in Patients With Progressive or Symptomatic Epithelioid Hemangioendothelioma Sirolimus for injection (Albumin-bound) - Epithelioid Hemangioendothelioma | Phase 2 | Not yet recruiting | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 40 | 2026-08-01 | 2026-07-06 |
| Luvometinib in Combination With Serplulimab for NF2-Related Tumors Luvometinib, Serplulimab - NF2-related Schwannomatosis, NF2 | Phase 1 / Phase 2 | Not yet recruiting | Beijing Tiantan Hospital | 30 | 2026-07-31 | 2026-07-16 |
| DEXmedetomidine for Postoperative Analgesia and Delirium Prevention After NEUROsurgery (DEX-NEURO Trial) Dexmedetomidine, Normal Saline (0.9% NaCl) - Neurosurgery, Brain Cancer | Not applicable | Not yet recruiting | University of Malaya | 60 | 2026-07-22 | 2026-02-09 |
| Platform Research for Innovative Medicines in NF2-SWN (PRIME-NF2) Selumetinib 25mg/m2, Luvometinib, Serplulimab - Neurofibromatosis Type 2, Vestibular Schwannoma | Phase 2 | Not yet recruiting | Beijing Tiantan Hospital | 200 | 2026-07-18 | 2026-07-20 |
| A Study of JZP3507 (ONC206) in Recurrent Grade 2 or 3 Meningioma JZP3507 - Meningioma | Phase 2 | Recruiting | Jazz Pharmaceuticals | 30 | 2026-07-16 | 2026-07-30 |
| Selumetinib for NF2-Related Schwannomatosis Selumetinib - Neurofibromatosis Type 2, NF2 | Phase 2 | Not yet recruiting | Beijing Tiantan Hospital | 20 | 2026-07-15 | 2026-07-16 |
| Search for Circulating Tumour Cells in the Blood and/or Cerebrospinal Fluid in Patients With Recurrent Aggressive Meningiomas: Proof-of-concept Study Blood sampling, Lumbar puncture - Meningioma | Not applicable | Recruiting | University Hospital, Montpellier | 15 | 2026-07-13 | 2026-07-14 |
Showing 20 of 640. Sign in to see all of them.
Meningioma (240) · Sarcoma, Kaposi (154) · Brain Neoplasms (102) · Sarcoma (102) · Hemangiosarcoma (91) · Glioma (70) · Acquired Immunodeficiency Syndrome (61) · HIV Infections (61) · Astrocytoma (59) · Glioblastoma (57) · Hemangioma (57) · Oligodendroglioma (53) · Ependymoma (50) · Liposarcoma (50) · Neoplasms (48)
Neoplasms by Histologic Type (640) · Neoplasms (592) · Nervous System Diseases (343) · Neoplasms by Site (313) · Neoplasms, Nerve Tissue (302) · Nervous System Neoplasms (285) · Neoplasms, Connective and Soft Tissue (261) · Meningeal Neoplasms (239) · Central Nervous System Neoplasms (203) · DNA Virus Infections (162) · Virus Diseases (161) · Herpesviridae Infections (160) · Infections (160) · Sarcoma (157)
Doxorubicin (28) · Magnetic Resonance Spectroscopy (22) · Propranolol (22) · Bevacizumab (15) · Ifosfamide (15) · Paclitaxel (13) · Sirolimus (13) · Radiotherapy (12) · Nivolumab (11) · Vincristine (11) · pembrolizumab (11) · Everolimus (10) · Specimen Handling (10) · Timolol (10) · Bleomycin (9)
National Cancer Institute (NCI) (56) · European Organisation for Research and Treatment of Cancer - EORTC (17) · National Institute of Allergy and Infectious Diseases (NIAID) (17) · AIDS Malignancy Consortium (13) · Memorial Sloan Kettering Cancer Center (9) · University of California, San Francisco (9) · West China Hospital (9) · Beijing Tiantan Hospital (8) · M.D. Anderson Cancer Center (8) · Massachusetts General Hospital (8) · Central Hospital, Nancy, France (7) · Medical College of Wisconsin (7) · Wake Forest University Health Sciences (7) · Assistance Publique - Hôpitaux de Paris (6) · Northwestern University (6)
United States (361) · France (64) · China (44) · Germany (26) · United Kingdom (26) · Canada (25) · Italy (23) · Spain (21) · Netherlands (17) · Belgium (16) · Denmark (15) · Switzerland (14) · Australia (10) · Austria (10) · Poland (10)
Robert Yarchoan, M.D. (10) · Ramya M Ramaswami, M.D. (7) · Beth Drolet, MD (4) · Alexander Dmitriev, MD (3) · Anne M Comi, M.D. (3) · Dirk Dittmer, PhD (3) · Edward G. Shaw, MD (3) · Gill PS (3) · Maria Garzon, MD (3) · Prashant Chittiboina, M.D. (3) · Susan E. Krown, MD (3) · Thomas Kaley, MD (3) · Yi Ji, MD, PhD (3) · Anhua Wu, MD (2) · Anne Lucky, MD (2)
PMID 35030255, PMID 19451433, PMID 22871490, PMID 28486787, PMID 31401903, PMID 31489702, PMID 32014025, PMID 33580918, PMID 37740179, PMID 41845569, PMID 11273919, PMID 11410496, PMID 11705489, PMID 11810123, PMID 12528778, PMID 12957454, PMID 14750917, PMID 15010069, PMID 15177491, PMID 15592836, PMID 15633090, PMID 15652610, PMID 15659504, PMID 15750399, PMID 16127110, PMID 16528479, PMID 16549835, PMID 16914578, PMID 17095209, PMID 17109446, PMID 17269969, PMID 17336054, PMID 17634494, PMID 17846226, PMID 18056189, PMID 18079362, PMID 18224669, PMID 18384551, PMID 18470481, PMID 18633018, PMID 18728566, PMID 18809609, PMID 19088049, PMID 19419474, PMID 19451429, PMID 19833796, PMID 20157038, PMID 20338746, PMID 20407240, PMID 20434400
U01CA121947 (6), UM1CA121947 (6), U01CA070019 (5), U54NS065705 (5), P30CA008748 (4), U10CA032102 (4), U10CA081851 (4), 2009 (3), P30CA043703 (3), U01CA062399 (3), N01CM62206 (2), P30CA016672 (2), P30CA033572 (2), P30CA060553 (2), P30CA138292 (2)